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Standing up for immunology
Ann Ager is chair of its Forum and a trustee for the British Society for Immunology, and council member of the International Union of Immunological Societies. She discusses her role as an advocate for immunology to governments and other policy makers.
Ann Ager W hen I look back over my career in academic immunology, I recall working to deadlines most of the time, what with a PhD thesis to produce, then papers and grant proposals to write, and (when my research became known) reviews to write. So why would I put myself forward to represent the interests of immunology and immunologists to governments and other policy makers?
Taking a stand locally
Given the limited opportunities to take a stand during my school days, I took advantage of the opportunity to take on the role of departmental chair of immunology while a postdoctoral fellow early in my career. In this administrative role, I learned how a department needs to be managed and that the opinions of all staff need to be taken into consideration before taking any action. This experience was invaluable in teaching me how to manage my own research group as it slowly increased in size. I also learned that an organization, be it your own research group, department, faculty or learned society, is its members, and the role of the committee or board, which represents its members, is to defend them from both internal and external attacks, such as budget cuts and questions of scientific credence.
Branching outside the academic sector
After several decades of 'putting myself forward' in the academic sector, I had accumulated a wide range of experience as a supervisor, teacher and mentor, as well as serving as president of the UK Cell Adhesion Society (http://ukcelladhesion. org/) and scientific advisor for European patent attorneys and external boards, such as those of funding agencies and biopharmaceutical companies. My first position as an advocate for immunology to government and other policy makers outside the academic research sector was as a member of the Special Interest Group for Cell and Gene Therapy set up by the chief medical officer in Wales. Health policy has devolved to the Welsh government, and this interest group was established to consider several aspects relating to the newly emerging types of cellular therapies for cancer and regeneration of damaged tissues. This group provided policy advice about how to deliver cellular therapies to patients within the National Health Service, about investment in establishing good manufacturing practice (GMP) facilities, and about education and high-level training to develop and translate new research on cellular therapies to patients. The work toward these goals is ongoing, but the first outcome of this committee has been setting up a UK Advanced Therapies Treatment Centre in Wales, funded by an Innovate UK award.
With this experience under my belt, I wanted to contribute to my own learned society, the British Society for Immunology (BSI). I had joined the BSI as an early-career researcher more than 30 years ago and have benefited enormously from the excellent and tailored support offered by the society at all stages of my career in immunology. I stood for, and was elected to, the chair of the BSI Forum for four years starting in 2019. The Forum is the BSI's committee (think tank) charged with developing policy and overseeing other areas of activity for the society. These activities include education and careers work, public engagement, media, policy and public affairs, which includes helping to formulate responses to external consultations. The role of the Forum is to help implement the strategic plan by providing a mechanism by which the voice of the membership can be fed into new activities to support education and training, patients and science policy in the immunology sector (see https://www. immunology.org/publications/immunologynews/immunology-news-june-2019/ introduction-the-british-society-for).
Advocating for immunology to the government
What are the challenges in advocating for evidence-based health and science policy relating to immunology to national governments in the UK? The first is that a minority of members of Parliament (MPs) have degrees in science, technology, engineering and mathematics (STEM) subjects, with very few in biological sciences, including immunology. However, in my short time working on the Forum, I have learned that MPs have great interest in immunology from personal, professional and political points of view. My experience in public engagement, such as 'Soapbox Science' , 'Tackling Cancer in Wales' and media interviews, has taught me that there is great public interest in the immune system, yet there are relatively few reliable sources of information about how to look after your immune system. The realization that altered immunity underlies many common disorders not traditionally viewed as immune mediated, such as dementia and atherosclerosis, and the emerging importance of the gut microbiome in immunity, emphasize the important role the BSI has in educating the public and national governments in how to maintain a healthy immune system.
There are several different approaches that are being utilized by the BSI to advocate for immunology. They regularly respond to government and parliamentary consultations on issues of importance to immunology and the life scienceseverything from immigration policy to how to extend a healthy lifespan. Additionally, they engage with MPs directly to ask them to table specific questions to ministers in charge of government departments.
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A particular focus of this work has been increasing childhood vaccination uptake. With the government due to announce a new vaccine strategy any day, it is an area of work where the organization has achieved considerable impact and success.
The BSI has also joined forces with others in the biosciences field, such as the Royal Society of Biology, to put forward a strong voice for life sciences; for example, by participating in Parliamentary Links Day, an established and respected event in the annual parliamentary calendar to strengthen dialog between Parliament and the science community (https://www.rsb. org.uk/policy/policy-events/parliamentarylinks-day). I hosted my own MP at the Parliamentary Links Day on 'Science and the New Frontiers' in July 2019 and initiated discussions about investment opportunities in precision medicine for economic growth and specialist education and training in the immunology sector in Wales.
Advocating for immunology to other policy makers
The BSI is working hard to increase the impact and output of immunology across the life sciences spectrum. In April 2019, the BSI launched a partnership with the National Cancer Research Institute to bring the two communities together to drive collaborations that will address challenges in immunotherapy, thereby speeding discovery and knowledge transfer to bring positive change to the lives of people living with cancer. They have also established a collaboration called Connect Immune Research, working with the Juvenile Diabetes Research Foundation, Versus Arthritis and the Multiple Sclerosis Society to promote a joined-up approach to research on autoimmunity to generate advances in understanding and in treatments for people living with autoimmune conditions. Advocacy for immunology is critical to maintaining the UK's standing as first among G7 countries in quality of immunology research and to prevent the emergence of a skills gap due to the increased use of biologics such as antibodies and cellular therapies in clinical practice.
How to get involved
Committee work and voicing your opinion in public is excellent training for leading a research team. However, I can see, and appreciate, deadline-induced stress in my own students and postdoctoral fellows that may put them off taking on these roles. By carefully selecting the committee that you want to work for, it is possible to factor this into your day job. Depending on the committee, you may have to stand for election, which will involve getting yourself nominated and writing an election statement. If elections are not required, you can self nominate or ask colleagues to nominate you, but it is important to remember that you will be representing the opinions of others as well as yourself, and you must therefore be an active committee member. Furthermore, making a difference to the way scientific policy is determined is hugely fulfilling, and even more so as part of a team. ❐
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